CAIRO: Liver centers treating hepatitis C will be increased from 114 to 194 by the end of 2016, Health Minister Ahmed Emad el-Din stated Tuesday.
Outlets dispensing hepatitis C treatments have been increased from 15 to 84 in the past months, Emad el-Din said, adding that 270,000 patients have been treated for the disease at the expense of the state.
The ministry also reduced the price of Sovaldi from 2,200 EGP to 520 EGP, and Daklinza from 1,315 EGP to 71 EGP. Both drugs are now manufactured in Egypt and are used together to treat patients over a six-month regimen.
The government targets 600,000 patients at a cost of 2 billion EGP, the statement said.
There are 3.6 million people within the age group of one day to 59 years old who suffer from Hepatitis C in Egypt, and 1-1.5 million more if the age group increases to 80 years old, according to a survey by the ministry.